{"entity":{"type":"insider","cik":"0001331438","url":"/insider/0001331438","json_url":"/insider/0001331438.json","name":"Baker Mark Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":60,"n_filings":28,"first":"2010-03-18","last":"2013-03-28","span_basis":"filed_date"},"name_variants":[{"name":"Baker Mark Robert","source":"filing","n_filings":28,"first_seen":"2010-03-18","last_seen":"2013-03-28"}],"transactions":[{"id":4661002,"accession":"0001447348-13-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001447348-13-000010","line_url":"/filing/0001447348-13-000010","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650.0,"shares_display":"650","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":3458.0,"total_display":"3,458.00","total_whole":"3,458","shares_owned_after":160991.0,"shares_owned_after_display":"160,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-27","filed_date":"2013-03-28","scope":"insider","n_lines":3},{"id":4502948,"accession":"0001447348-13-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001447348-13-000004","line_url":"/filing/0001447348-13-000004","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1262.0,"shares_display":"1,262","price_per_share":2.721434231378764,"price_display":"2.72","price_state":"stated","total_value":3434.45,"total_display":"3,434.45","total_whole":"3,434","shares_owned_after":160264.0,"shares_owned_after_display":"160,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-27","filed_date":"2013-02-28","scope":"insider","n_lines":3},{"id":4316031,"accession":"0001447348-13-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-13-000002","line_url":"/filing/0001447348-13-000002","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1215.0,"shares_display":"1,215","price_per_share":2.8225925925925925,"price_display":"2.82","price_state":"stated","total_value":3429.45,"total_display":"3,429.45","total_whole":"3,429","shares_owned_after":158914.0,"shares_owned_after_display":"158,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-22","filed_date":"2013-01-23","scope":"insider","n_lines":2},{"id":3254319,"accession":"0001447348-12-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-12-000049","line_url":"/filing/0001447348-12-000049#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1142.0,"shares_display":"1,142","price_per_share":3.01,"price_display":"3.01","price_state":"stated","total_value":3437.42,"total_display":"3,437.42","total_whole":"3,437","shares_owned_after":158014.0,"shares_owned_after_display":"158,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-26","filed_date":"2012-12-26","scope":"insider"},{"id":2813515,"accession":"0001447348-12-000047","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001447348-12-000047","line_url":"/filing/0001447348-12-000047","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1607.0,"shares_display":"1,607","price_per_share":2.1273055382700683,"price_display":"2.13","price_state":"stated","total_value":3418.58,"total_display":"3,418.58","total_whole":"3,419","shares_owned_after":156865.0,"shares_owned_after_display":"156,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-28","filed_date":"2012-11-30","scope":"insider","n_lines":6},{"id":3523504,"accession":"0001441844-12-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-12-000004","line_url":"/filing/0001441844-12-000004#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11800.0,"shares_display":"11,800","price_per_share":1.958,"price_display":"1.96","price_state":"stated","total_value":23104.4,"total_display":"23,104.40","total_whole":"23,104","shares_owned_after":155265.0,"shares_owned_after_display":"155,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-19","filed_date":"2012-11-20","scope":"insider"},{"id":3548364,"accession":"0001441844-12-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-12-000003","line_url":"/filing/0001441844-12-000003#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49793.0,"shares_display":"49,793","price_per_share":1.822,"price_display":"1.82","price_state":"stated","total_value":90722.846,"total_display":"90,722.85","total_whole":"90,723","shares_owned_after":143465.0,"shares_owned_after_display":"143,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-16","filed_date":"2012-11-19","scope":"insider"},{"id":3351973,"accession":"0001441844-12-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-12-000002","line_url":"/filing/0001441844-12-000002#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48833.0,"shares_display":"48,833","price_per_share":1.686,"price_display":"1.69","price_state":"stated","total_value":82332.438,"total_display":"82,332.44","total_whole":"82,332","shares_owned_after":93672.0,"shares_owned_after_display":"93,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-15","filed_date":"2012-11-16","scope":"insider"},{"id":2228032,"accession":"0001447348-12-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-12-000045","line_url":"/filing/0001447348-12-000045#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1162.0,"shares_display":"1,162","price_per_share":2.955,"price_display":"2.96","price_state":"stated","total_value":3433.71,"total_display":"3,433.71","total_whole":"3,434","shares_owned_after":44839.0,"shares_owned_after_display":"44,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-24","filed_date":"2012-10-25","scope":"insider"},{"id":2932930,"accession":"0001447348-12-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-12-000043","line_url":"/filing/0001447348-12-000043#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1036.0,"shares_display":"1,036","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":3439.52,"total_display":"3,439.52","total_whole":"3,440","shares_owned_after":43677.0,"shares_owned_after_display":"43,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-26","filed_date":"2012-09-27","scope":"insider"},{"id":3424151,"accession":"0001447348-12-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-12-000042","line_url":"/filing/0001447348-12-000042#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":815.0,"shares_display":"815","price_per_share":4.234,"price_display":"4.23","price_state":"stated","total_value":3450.71,"total_display":"3,450.71","total_whole":"3,451","shares_owned_after":42641.0,"shares_owned_after_display":"42,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-22","filed_date":"2012-08-23","scope":"insider"},{"id":3318141,"accession":"0001447348-12-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-12-000041","line_url":"/filing/0001447348-12-000041#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":346.0,"shares_display":"346","price_per_share":10.037,"price_display":"10.04","price_state":"stated","total_value":3472.802,"total_display":"3,472.80","total_whole":"3,473","shares_owned_after":41826.0,"shares_owned_after_display":"41,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-25","filed_date":"2012-07-26","scope":"insider"},{"id":2176399,"accession":"0001447348-12-000039","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001447348-12-000039","line_url":"/filing/0001447348-12-000039","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375.0,"shares_display":"375","price_per_share":9.27288,"price_display":"9.27","price_state":"stated","total_value":3477.33,"total_display":"3,477.33","total_whole":"3,477","shares_owned_after":41380.0,"shares_owned_after_display":"41,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-27","filed_date":"2012-06-29","scope":"insider","n_lines":4},{"id":2314517,"accession":"0001447348-12-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-12-000027","line_url":"/filing/0001447348-12-000027#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":445.0,"shares_display":"445","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":3475.45,"total_display":"3,475.45","total_whole":"3,475","shares_owned_after":41105.0,"shares_owned_after_display":"41,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-23","filed_date":"2012-05-24","scope":"insider"},{"id":2932915,"accession":"0001447348-12-000024","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001447348-12-000024","line_url":"/filing/0001447348-12-000024","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":348.0,"shares_display":"348","price_per_share":10.074712643678161,"price_display":"10.07","price_state":"stated","total_value":3506.0,"total_display":"3,506.00","total_whole":"3,506","shares_owned_after":40445.0,"shares_owned_after_display":"40,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-25","filed_date":"2012-04-27","scope":"insider","n_lines":4},{"id":3548398,"accession":"0001447348-12-000020","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001447348-12-000020","line_url":"/filing/0001447348-12-000020","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":343.0,"shares_display":"343","price_per_share":10.131603498542274,"price_display":"10.13","price_state":"stated","total_value":3475.14,"total_display":"3,475.14","total_whole":"3,475","shares_owned_after":40312.0,"shares_owned_after_display":"40,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-29","scope":"insider","n_lines":3},{"id":2102849,"accession":"0001447348-12-000009","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001447348-12-000009","line_url":"/filing/0001447348-12-000009","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":369.0,"shares_display":"369","price_per_share":9.414037940379403,"price_display":"9.41","price_state":"stated","total_value":3473.78,"total_display":"3,473.78","total_whole":"3,474","shares_owned_after":39766.0,"shares_owned_after_display":"39,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-22","filed_date":"2012-02-23","scope":"insider","n_lines":5},{"id":3098165,"accession":"0001447348-12-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001447348-12-000004","line_url":"/filing/0001447348-12-000004","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":364.0,"shares_display":"364","price_per_share":9.534120879120879,"price_display":"9.53","price_state":"stated","total_value":3470.42,"total_display":"3,470.42","total_whole":"3,470","shares_owned_after":39500.0,"shares_owned_after_display":"39,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-25","filed_date":"2012-01-26","scope":"insider","n_lines":6},{"id":3403362,"accession":"0001447348-12-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001447348-12-000003","line_url":"/filing/0001447348-12-000003","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":391.0,"shares_display":"391","price_per_share":8.865115089514067,"price_display":"8.87","price_state":"stated","total_value":3466.26,"total_display":"3,466.26","total_whole":"3,466","shares_owned_after":39236.0,"shares_owned_after_display":"39,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-11","filed_date":"2012-01-12","scope":"insider","n_lines":2},{"id":8933413,"accession":"0001447348-11-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-11-000019","line_url":"/filing/0001447348-11-000019#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":634.0,"shares_display":"634","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":3455.3,"total_display":"3,455.30","total_whole":"3,455","shares_owned_after":38313.0,"shares_owned_after_display":"38,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-23","filed_date":"2011-11-28","scope":"insider"},{"id":3403358,"accession":"0001447348-12-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001447348-12-000003","line_url":"/filing/0001447348-12-000003#line-3","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":455.0,"shares_display":"455","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":2966.6,"total_display":"2,966.60","total_whole":"2,967","shares_owned_after":38135.0,"shares_owned_after_display":"38,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-26","filed_date":"2012-01-12","scope":"insider"},{"id":3403355,"accession":"0001447348-12-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000003","line_url":"/filing/0001447348-12-000003#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001331438","owner_name":"Baker Mark Robert","owner_display_name":"Baker Mark Robert","owner_url":"/insider/0001331438","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76.0,"shares_display":"76","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":494.0,"total_display":"494.00","total_whole":"494","shares_owned_after":38211.0,"shares_owned_after_display":"38,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-26","filed_date":"2012-01-12","scope":"insider"}],"collapsed":true,"next_cursor":"2011-10-26|3403355","ledger_fault":false,"count":{"value":60,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":57,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":60},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Director, Officer (CEO)","n_filings":28,"first_seen":"2010-03-18","last_seen":"2013-03-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001331438","retrieved_at":"2026-08-25T12:58:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}